Further studies that better discern the mechanism of inhibition of colon polyposis by mTOR inhibitors in mouse models are expected to be of considerable benefit in developing new approaches and agents for the inhibition of polyposis in FAP patients and perhaps in other patient populations with APC-mutant colorectal tumors. The gene discussed is MTOR; the disease is Familial adenomatous polyposis.